Company overview
Basic information
Company name
Delseta, UAB
Company code
304146888
VAT code
LT100010567717
Registered address
Vilnius, Architektų g. 56-101, LT-04111
Registration date
2015-12-03
Company age: 10 y. 10 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Sawmilling and planing of wood
Sector
Užsienio subjektų kontroliuojamos ne finansų bendrovės
Ownership form
Private foreign capital
UAB "Delseta"
Company code: 304146888
Address: Vilnius, Architektų g. 56-101, LT-04111
VAT code: LT100010567717
Description
This description was generated by artificial intelligence.
Delseta, UAB is an operational private limited liability company registered on 3 December 2015. The company code is 304146888. It is classified as a private company with private ownership, where foreign natural and legal persons hold more than 50% of the authorised capital, and it is part of the non-financial companies controlled by foreign entities sector. Governance is listed as CEO only, and the company is categorised as micro. Delseta, UAB is based in Vilnius, Vilniaus m. sav., Vilniaus apskr., at Architektu g. 56-101, LT-04111. Its core activity is EVRK C.16.11.00, Sawmilling and planing of wood. The registered share capital is €2.5K. Financially, the company reported revenue of €158.4K in 2025, up markedly from €17.6K in 2024, and returned to profitability with net profit of €1.1K after a net loss of €5.9K in 2024. The 2025 profit margin was 0.7%. The company had 3 average employees in 2023, 2024 and 2025, and 3 average employees so far in 2026.
Download a detailed company report
Make confident decisions with all the information about Delseta, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.